Esztergom-kertvaros, Hungary

Peter Kalvin


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Peter Kalvin

Introduction

Peter Kalvin is a notable inventor based in Esztergom-kertvaros, Hungary. He has made significant contributions to the field of chemistry, particularly in the synthesis of high-purity compounds. His work is characterized by a focus on innovative processes that enhance the quality and efficiency of chemical synthesis.

Latest Patents

Kalvin holds a patent for a process titled "Process for the synthesis of high purity 3,5-diamino-6-(2,3-dichlorophenyl) (1,2,4-triazine)." This invention relates to a new method for synthesizing high-purity 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine using 2,3-dichlorobenzoyl cyanide and an aminoguanidine salt as starting materials. The process involves reacting 2,3-dichlorobenzoyl cyanide with 1-2 mol equivalents of aminoguanidine salt in 3-6 mol equivalents of methanesulfonic acid. The resulting adduct is then transformed into the final product using magnesium oxide. The crude product can be recrystallized from an appropriate organic solvent, ensuring high purity.

Career Highlights

Kalvin is associated with Richter Gedeon Vegyeszeti Gyar Rt, a prominent pharmaceutical company in Hungary. His role at the company has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in pharmaceutical chemistry.

Collaborations

Throughout his career, Kalvin has collaborated with esteemed colleagues such as Jozsef Neu and Tibor Gizur. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of their research.

Conclusion

Peter Kalvin's contributions to the field of chemistry through his innovative patent and collaborative efforts highlight his importance as an inventor. His work continues to influence the synthesis of high-purity compounds, showcasing the impact of innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…